Advances in Gynecological Cancer Research: Emerging Technologies and Future Therapeutic Strategies

A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Obstetrics and Gynecology".

Deadline for manuscript submissions: 31 May 2025 | Viewed by 922

Special Issue Editors


E-Mail
Guest Editor
Department of Obstetrics & Gynecology, Korea University College of Medicine, Seoul, Republic of Korea
Interests: gynecologic oncology; robotic surgery; minimally invasive surgery; clinical trial; circulating tumor cells

E-Mail
Guest Editor Assistant
Department of Obstetrics & Gynecology, Korea University College of Medicine, Seoul, Republic of Korea
Interests: gynecologic oncology; robotic surgery; minimally invasive surgery; artificial intelligence; genomic profiling

Special Issue Information

Dear Colleagues,

This Special Issue focuses on the latest advancements in gynecological cancer research, highlighting cutting-edge developments in the field. We invite contributions that explore innovative surgical techniques, novel drug therapies, and the role of genomic profiling in personalized treatment approaches. Additionally, this issue will cover the integration of artificial intelligence (AI) and machine learning (ML) in improving diagnostic accuracy and treatment outcomes in gynecological oncology.

By encompassing a wide range of topics, this Special Issue aims to present a comprehensive view of the future of gynecological cancer care.

Prof. Dr. Jae-Yun Song
Guest Editor

Dr. Seongmin Kim
Guest Editor Assistant

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • gynecological cancer
  • innovative surgical techniques
  • genomic profiling
  • personalized medicine
  • artificial intelligence (AI) in oncology
  • machine learning in diagnosis
  • cancer research technologies
  • future therapeutic strategies

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

10 pages, 832 KiB  
Article
Does Frequent Use of Advanced Energy Devices Improve Hysterectomy Outcomes?
by Hyunkyoung Seo, Seon-Mi Lee, Aeran Seol, Seongmin Kim, Sanghoon Lee and Jae-Yun Song
Medicina 2024, 60(12), 1978; https://doi.org/10.3390/medicina60121978 - 2 Dec 2024
Viewed by 543
Abstract
Background and Objectives: The objective of this study was to assess the efficient use of advanced energy devices by examining the impact of their usage frequency on surgical outcomes of total laparoscopic hysterectomies. Materials and Methods: A retrospective study was conducted [...] Read more.
Background and Objectives: The objective of this study was to assess the efficient use of advanced energy devices by examining the impact of their usage frequency on surgical outcomes of total laparoscopic hysterectomies. Materials and Methods: A retrospective study was conducted between 2020 and 2023 by a single surgeon. The patients’ medical records and surgical videos were reviewed. Cases were categorized into three groups based on the frequency of usage of advanced energy devices: Group 1 (≤10 uses), Group 2 (11–20 uses), and Group 3 (≥21 uses). The differences in blood loss, surgery time, and surgical outcomes among these groups were analyzed. This study was conducted as a single-center retrospective analysis. It included 126 patients who underwent total laparoscopic hysterectomy and provided informed consent for video recording. To evaluate the usage of advanced energy devices, anonymized surgical videos were reviewed, and outcomes were analyzed based on the frequency of usage of advanced energy devices. Results: The time required for surgery differed significantly among the three groups (p = 0.006). However, no significant differences were observed in the changes in hemoglobin levels or estimated blood loss (p = 0.255 and 0.053, respectively). Additionally, the application of hemostatic agents, the need for intraoperative or postoperative transfusions, and the use of intravenous hemostatic agents postoperatively showed no notable variation. Complication rates, including rates of hematoma, urinary tract injury, gastrointestinal injury, and infections necessitating reoperation, were also comparable. Conclusions: The findings suggest that the prudent and strategic use of advanced energy devices, rather than their frequent application, may improve surgical efficiency without increasing the risk of complications. Full article
Show Figures

Figure 1

Back to TopTop